Form 4 filed by Lappe Mark
Lappe Mark filed this Form 4 on Inhibrx Biosciences, Inc. with 4 transaction rows and 2 holding rows, accepted by EDGAR 2026-09-28 21:47:30 UTC.
- Accession
- 0001366074-26-000004
- Filer
- CIK 1366074
- Filed
- 2026-09-28
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Inhibrx Biosciences, Inc. (CIK 2007919)
- Lappe Mark director, officer (Chief Executive Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-09-25 | P bought | +3,324 | $98.8659 | 733,872 | I By the Lappe Family Trust |
| Common Stock | 2026-09-25 | P bought | +2,176 | $99.5988 | 736,048 | I By the Lappe Family Trust |
| Common Stock | 2026-09-28 | P bought | +1,500 | $98.8803 | 737,548 | I By the Lappe Family Trust |
| Common Stock | 2026-09-28 | P bought | +3,000 | $101.702 | 740,548 | I By the Lappe Family Trust |
| Common Stock holding | 165,000 | I By Lappe Descendants' Trust | ||||
| Common Stock holding | 54,865 | I The Mark Paul Lappe Roth IRA |